Rick Simpson Oil (RSO) in Candler County, Georgia: The Complete Guide by OilWell Cannabis

If you’re reading this in Metter, Pulaski County just over the line, or anywhere among the pine forests and farmland that define Candler County, you’re probably looking for honest answers about Rick Simpson Oil. Maybe you heard about it from a neighbor at the Candler County Farmers Market. Maybe your doctor in Statesboro mentioned it as something to research. Maybe you’re up late, searching on your phone from the quiet of your porch out on Highway 121, wondering if this cannabis extract could help with pain that won’t quit, with the side effects of chemo, with the anxiety that keeps you from sleeping, or with the PTSD that makes every day feel like a battle.

We get it. And we’re here to give you the truth—not hype, not miracle stories, just what we’ve learned from years of formulation work, from the science we can verify, and from the people whose lives have actually changed because of this plant medicine. We started OilWell Cannabis in Houston, Texas, but our story begins in the kind of hardscrabble places that would feel familiar to anyone from McAllen, Georgia or the rural stretches of Candler County. We built this company because the medical system failed us, failed our dog Bentley, and failed people we love. We’re not doctors. We’re not here to sell you snake oil. We’re here to give you the best possible version of the information so you can decide for yourself what’s right for you.

Understanding Rick Simpson Oil: The Man, The Myth, The Science

Who Was Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia—about as far from Candler County as you can get, yet his story resonates in rural communities everywhere. He wasn’t a doctor, a scientist, or a researcher. He was a power engineer and maintenance worker, a blue-collar tradesman who got hurt on the job in 1997 when he fell from scaffolding at a hospital in Moncton, New Brunswick. The aftermath was brutal: persistent tinnitus, dizziness, post-concussion symptoms that the medications his doctors prescribed either couldn’t fix or made worse. When he asked his physician about cannabis, the doctor refused to even discuss it.

Sound familiar? If you’ve ever felt dismissed by a medical provider, if you’ve ever been handed another prescription that didn’t work, if you’ve ever sat in a waiting room at Candler County Hospital and left feeling like you had more questions than answers—you know exactly why Simpson started looking elsewhere.

Simpson’s interest deepened after learning about a 1974 study at the Medical College of Virginia, funded by the National Institute of Health, where THC reportedly slowed or shrank tumors in mice. That study was originally designed to show harm, not benefit, and its findings—however intriguing—were never replicated in controlled human cancer trials. But for Simpson, it was a lightbulb moment.

The real turning point came in 2003. Three bumps on his arm were diagnosed as basal cell carcinoma. Instead of pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared in four days. No biopsy confirmation. No independent medical verification. No published peer-reviewed documentation. Just his personal testimony.

Important context: This is personal testimony, not medical evidence. We tell you this because honesty matters more than hype. Simpson’s story is historically significant—it sparked a global movement—but it cannot be evaluated as clinical proof. People in Candler County deserve to know the difference.

The Crusade: Spreading The Oil

After 2003, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free. He charged nothing. He claimed to help people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia—you name it. He made the oil in large batches, handed it out in oral syringes, and built a grassroots network that believed cannabis oil could heal.

His story went global through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film was distributed freely online and became foundational in cannabis communities worldwide. For many people searching “RSO” today—even here in Candler County—that documentary was their introduction to the idea of cannabis as concentrated medicine.

But Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and again in 2009. He was charged with cultivation, possession, and trafficking. Eventually, facing continued legal pressure, Simpson left Canada for Europe, living in Croatia and later the Netherlands, where he continued his advocacy from abroad.

Throughout his public career, Simpson remained uncompromising. He maintained that RSO could cure cancer and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge. He framed his work as a fight against institutional corruption.

Another important context: Simpson’s conspiratorial framing reflects a worldview shared by many in the early cannabis movement. It helps explain why RSO became culturally significant, but it doesn’t replace scientific evidence. We respect Simpson’s contribution while holding ourselves to a higher standard of proof.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson’s core recommendation was a structured oral protocol: consume 60 grams of concentrated cannabis oil over roughly 90 days. Here’s exactly what he prescribed:

Goal: 60 grams of high-THC cannabis oil in about 90 days.

Titration schedule:

• Week 1: Start with a dose the size of half a grain of rice—about 10-15mg of oil—three times daily. Total daily intake: ~30-45mg.
• Weeks 2-5: Double the dose every four days. By the end of week five, reach approximately 1 gram (1,000mg) per day, divided into three doses of ~333mg each.
• Weeks 5-12: Maintain 1 gram per day until all 60 grams are consumed.

Administration methods:

• Primary: Oral (sublingual or swallowed) for systemic absorption.
• Secondary: Topical for skin cancers and lesions, combined with oral dosing.
• Not recommended: Inhalation as primary treatment, though Simpson acknowledged it for immediate symptom relief.

Tolerance and psychoactive effects: Simpson claimed patients develop tolerance within 3-4 weeks and that the high is temporary. He recommended nighttime dosing initially and warned against driving.

Post-protocol maintenance: After completing 60 grams, Simpson recommended 1-2 grams per month indefinitely.

Dietary recommendations: Reduce sugar, avoid processed foods, improve nutrition.

Critical Context for Evaluating This Protocol

This protocol has major limitations that anyone in Candler County needs to understand:

• No controlled trial validation. Zero published randomized controlled trials, cohort studies, or well-documented case series support this specific 60-gram/90-day protocol for any condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes a THC-dominant extract with no standardized potency. Traditional RSO’s THC content varied wildly depending on starting plant material.
• Very high THC exposure. At peak dosing, patients consumed ~1 gram of high-THC oil daily. Assuming 60-90% THC, that’s 600-900mg of delta-9 THC per day. For context, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5-20mg per day. That’s a 30- to 360-fold difference.
• Real risks at these doses. Consuming 600-900mg of THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. These aren’t theoretical—they’re well-documented [1][13][14][15].
• Oncology context matters. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as a primary cancer treatment—potentially in place of proven therapies—introduces harm beyond the oil itself.

The bottom line for Candler County residents: If you’re considering RSO for cancer, please do it alongside your oncologist, not instead of them. Candler County Hospital and any cancer centers you might travel to in Statesboro or Savannah have teams that can help you navigate integrative approaches safely.

What Traditional RSO Actually Was

Understanding what Simpson made helps you understand why modern formulations are different:

Source material: Single high-THC indica strains, no standardization. Whatever he grew or sourced—that was your batch.

Extraction solvent: Naphtha (a petroleum-based solvent) or 99% isopropyl alcohol—neither food-grade. Naphtha may contain benzene, toluene, and other carcinogens.

Extraction process: Eight steps involving buckets, cheesecloth filters, rice cookers for evaporation, and oral syringes for storage. The rice cooker heat evaporated solvent but also decarboxylated all THCa into THC and destroyed most terpenes.

Appearance: Nearly black, thick, tar-like, sticky oil with a strong cannabis odor and possible solvent-residual smell.

Cannabinoid profile: THC-dominant (60-90% estimated), fully decarboxylated, with minor cannabinoids at whatever natural ratios the source strain contained—uncontrolled, unmeasured, never lab-verified.

Terpene content: Minimal to none. The solvent and heat process stripped them out.

Standardization: None. Every batch was different because it depended on plant material, growing conditions, solvent purity, extraction technique, evaporation temperature and duration, and the maker’s process.

Residual solvent risk: This is one of the biggest safety concerns. Incomplete solvent purging—difficult to verify without lab testing—leaves potentially harmful residues in the finished oil.

Simpson’s Claims vs. The Evidence

Let’s be direct about what the science actually shows:

What Simpson was not: A scientist, physician, pharmacologist, or researcher. He never designed, conducted, funded, or published a clinical trial. His evidence base was personal experience and testimonials—no controls, no independent verification, no imaging confirmation, no long-term follow-up, no blinding.

What the preclinical literature shows: In vitro studies show THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal models show some tumor-growth inhibition . These findings are scientifically interesting and justify ongoing research.

What the preclinical literature does NOT show: These findings have not translated into proven human cancer cures. The gap between in vitro/animal results and human clinical outcomes is vast. No human clinical trial has demonstrated that RSO or any cannabis oil cures cancer.

Institutional positions:

• National Cancer Institute (NCI): Acknowledges cannabinoid anticancer research but does not endorse cannabis as cancer treatment .
• FDA: Has not approved any cannabis plant product for cancer. Only approved cannabinoid-related products are for specific other indications [1].
• Health Canada: Never approved RSO or cannabis oil as cancer cure.
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1].

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world ignored them. He helped create conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: Cure claims exceeded the evidence. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential. Delayed or foregone treatment is a documented concern.

OilWell Cannabis: Built From Suffering, Guided by Science

The Origin Story

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But Colin’s story starts in McAllen, Texas—right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. It’s a place where poverty grinds against cartel violence, where opportunity is scarce outside retail and healthcare, and where survival requires hustle.

Colin’s childhood was marked by both opportunity and danger. By sixteen, he was transporting items across the border for various groups—risky work that exposed him to every form of violence imaginable. Many of his best friends were killed or ended up in prison. He had to leave home for good.

Despite the darkness, Colin didn’t fall into selling harder substances. He focused on cannabis, seeing it as safer and more beneficial. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Eventually, he transitioned to legal business.

Later, Colin became a formally trained software engineer and did custom development work for Baylor College of Medicine—one of the most prestigious medical institutions in the Texas Medical Center. That combination—deep cannabis plant knowledge plus medical-grade technical precision—defines OilWell’s approach.

Bentley: The Dog Who Started Everything

The company’s origin story begins with a dog named Bentley. Bentley wasn’t just a pet—he was family, the companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up wasn’t an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything. A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience—but it was recreational. He’d never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Determined to save Bentley, Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It wasn’t a cure, but it was a lifeline. And that hope delivered what veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. This wasn’t placebo—dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia led to CBC’s role in neurogenesis
• Glaucoma led to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone couldn’t address neurodegeneration and dementia and glaucoma and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

Colin’s Personal Battle: PTSD and Benzo Addiction

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a feat notoriously difficult and dangerous—using the cannabinoid knowledge he’d developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, the therapeutic benefits of cannabis that Colin first discovered through his efforts to save Bentley became the core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been on making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13: Seven Features, Four Years, One Voice

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out. No other Houston cannabis operator matches that frequency or breadth.

Why this matters for Candler County residents: Mainstream media validation from a major-market ABC affiliate establishes credibility that transcends geography. When the fourth-largest city in America repeatedly turns to the same expert, it means something. It means the information is solid, the character is trustworthy, and the story is worth telling.

Here are all seven features, preserved in full:

Feature 1: Texas CBD businesses booming — September 15, 2019

Reporter: Tom Abrahams

This was our first ABC13 feature and the origin point of our philosophy. The video description noted CBD was being pitched “for every member of the family, including pets”—an early indicator of our broad-spectrum approach.

Colin’s quote that defined us: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Feature 2: Entrepreneur creates direct-to-consumer business ahead of marijuana decriminalization — March 22, 2021

Reporter: Tom Abrahams

This feature showed Colin as an ecosystem builder, helping other entrepreneurs like Jonathan Pina enter legal cannabis. The national decriminalization context (Schumer, Booker, Wyden) positioned OilWell at the intersection of Texas innovation and federal momentum.

Key quote on therapy: “Pain comes in a lot of different forms.”

Feature 3: What is Delta 8 THC and why is it considered “legal weed” in Texas — May 24, 2021

Reporter: Steve Campion

This investigative piece became one of ABC13’s most referenced cannabis segments. The exchange where Colin said, “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high,” became iconic—radical honesty on mainstream TV.

Feature 4: Houston CBD shop giving away free products for COVID vaccine — August 20, 2021

Reporter: KTRK Staff

OilWell gave away 1,000 special edition caviar pre-rolls (valued at ~$35,000) to encourage COVID-19 vaccination. We coordinated with the city of Houston, with no political strings attached. This was documented community action, not marketing.

From our Instagram: “We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!”

Feature 5: Texas ban over once legal hemp product Delta 8 raises questions over legality — October 19, 2021

Reporter: Shelley Childers

When Delta-8 was classified as Schedule I overnight, Colin proactively removed all products before enforcement began and warned other operators who were unknowingly shipping Schedule I narcotics. We absorbed a major revenue loss to act ethically.

Key warning: “So those people are now, because they didn’t know, shipping Schedule 1 narcotics, and people are receiving it.”

Feature 6: Biden marijuana pardon — experts weigh in on why Texas won’t see impact — October 7, 2022

Reporter: Nick Natario

This feature revealed Colin’s personal marijuana conviction history. Our CBD vending machine debuted here, and Colin’s quote—”I would love to see people not get hurt for this anymore”—carried the weight of lived experience.

The personal revelation transforms everything. Every feature, every quote about therapy and education, carries additional weight when you understand the person saying it has personally experienced cannabis criminalization.

Feature 7: Marijuana industry getting creative as Texas laws continue to change — April 21, 2023

Reporter: Nick Natario

On 4/20/2023, Colin explained industry dynamics and legal strategy on camera with the confidence of a sector leader. His “Renaissance” framing positioned the present as opportunity rather than waiting.

Key quote: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”

The Through-Line: What Seven Features Reveal

Consistency across years. From 2019 to 2023, through every legal and market shift, ABC13 returned to Colin as a primary source.

Breadth of expertise. Business, law, medicine, community health, politics—no other Houston figure spoke to that range.

Community action. The COVID giveaway and proactive Delta-8 removal are documented evidence of community-first philosophy.

Personal stakes. The 2022 revelation of Colin’s conviction history makes every prior quote more powerful.

Evolution of language. From “local wholesaler” to industry authority to sector leader—the media record tracks real growth.

These features cannot be purchased. They can only be earned.

Our Four Core Principles

1. Accessibility Over Gatekeeping

No medical card required. Anyone age 21+ can purchase. We ship nationwide and internationally to customers who verify local legality.

For Candler County residents: You don’t need to drive to Statesboro or Savannah to see a special doctor. You don’t need to qualify under Georgia’s restrictive medical cannabis program (which only allows low-THC oil and requires specific qualifying conditions). You can order directly from our Houston facility and have it shipped discreetly to your doorstep in Metter, anywhere along Highway 46, or out in the rural stretches near George L. Smith State Park.

Simpson believed medicine should be accessible to everyone. We built a product and distribution model that makes that accessible legally.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency.

The conversion is simple: Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500mg of THCa into approximately 1,315mg of delta-9 THC. Combined with the existing 90mg of delta-9 THC, you get ~1,405mg total delta-9 THC—giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion.

For Candler County residents: This means one purchase serves multiple needs. Daytime functional use (raw) for working in the fields, driving into town, or parenting without impairment. Nighttime full-potency use (decarbed) for therapeutic strength when you need it. Vape format for instant relief during acute breakthrough pain or panic attacks.

Simpson believed patients should control their own medicine. We engineered a product that puts that control in your hands through chemistry.

3. Open-Source Formulas

We publish our complete formulas publicly. Every cannabinoid, every milligram amount, every percentage—detailed in this document.

For Candler County residents: If $129.99 for the sublingual oil or $49.99 for the vape cartridge is beyond your budget, you can see exactly what the formula contains, source the individual cannabinoid distillates and isolates, and make your own version. The formulas are in the sections below.

Simpson gave his oil away for free and taught people how to make it. He never patented his method. He never charged patients. We adapted that ethos: sell a professionally manufactured, lab-tested, standardized product for those who want it, and publish the complete recipe for those who want to make it themselves.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section of this document (pages 30-45) represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature or clinical trial data. We have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

For Candler County residents: You deserve to know the truth. If a cannabinoid has strong evidence (like CBD for seizures), we’ll say it confidently. If it’s emerging (like CBG for neurologic disorders), we’ll say so honestly. If it’s weak (like CBN for sleep), we’ll acknowledge the gap between marketing and evidence.

Farm Bill Compliance and the THCa Legal Framework

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our product design.

Our RSO Sublingual Oil contains only 90mg of delta-9 THC in the entire 30mL bottle—3mg per milliliter—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in Georgia.

Georgia-specific context: Georgia has a medical cannabis program, but it’s one of the most restrictive in the country. It only allows low-THC oil (up to 5% THC) for specific qualifying conditions. Our product is Farm Bill compliant, meaning it’s accessible without a medical card—even in Candler County, where the nearest medical cannabis dispensary might be hours away.

THCa distinction: THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This makes it Farm Bill compliant at point of sale because it hasn’t been converted to delta-9 THC.

Customer responsibility: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with Georgia law. We ship with full documentation, Certificates of Analysis, and receipts. If you’re in Candler County and concerned about legality, consult local law enforcement or legal counsel. We provide the paperwork; you make the informed decision.

The Decarboxylation Choice: Three Usage Options

Our sublingual formula contains 1,500mg of THCa in its acidic, non-psychoactive form. This creates three distinct usage options:

Option 1: Raw, No Heat (Non-Psychoactive)
All 1,500mg stays as THCa. Completely non-psychoactive. Compatible with work, driving, daytime parenting with zero impairment. The THCa evidence profile suggests potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12].

Option 2: Fully Activated, Home Decarboxylation
Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. Converts 1,500mg THCa into ~1,315mg delta-9 THC. Combined with the existing 90mg delta-9 THC, you get ~1,405mg total delta-9 THC. Combined with 6,000mg delta-8 THC, the activated product achieves psychoactive potency comparable to traditional illegal RSO—100% legally, because decarboxylation occurs at your discretion after purchase.

Option 3: Vape, Auto-Decarboxylation
Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Every inhalation delivers freshly decarboxylated cannabinoids. This is the fastest-onset RSO delivery method available.

Conversion chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1mg THCa = 0.877mg delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule.

For Candler County residents: This design puts the potency decision entirely in your hands. If you’re working a shift at the plant in Metter, driving a tractor, or need to stay sharp for family responsibilities, use it raw. If you’re dealing with nighttime pain, cancer symptoms, or severe anxiety that needs full-strength relief, decarb it. If you need instant breakthrough relief, vape it.

Solvent-Free Production: Why It Matters

Traditional RSO used naphtha or isopropyl alcohol—neither food-grade. Naphtha is a complex petroleum hydrocarbon mixture that may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging leaves harmful residues in the finished oil.

Our approach: We don’t extract with solvents. We formulate by blending individual cannabinoid distillates and isolates in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents in the finished product.

Carrier: Organic MCT oil (medium-chain triglycerides)—a food-grade lipid carrier that facilitates sublingual absorption and provides a neutral taste. This is a massive improvement over traditional RSO’s tar-like consistency and solvent-residual odor.

Third-party lab testing: Every batch is tested for cannabinoid potency, terpene profile, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and through our website.

For Candler County residents: If you’re buying cannabis products from informal sources—maybe someone local making “RSO” in their kitchen—you have no way to know what’s in it. Our testing ensures you’re getting exactly what’s on the label, with no contaminants. That’s peace of mind when you’re dealing with serious health conditions.

The OilWell Product Portfolio

Beyond RSO, we produce a range of cannabinoid products, each developed from the formulation knowledge Colin built over Bentley’s ten-year journey and his own PTSD/benzo experience:

Asshole Peach — Our most popular product. Carefully formulated for euphoric, long-lasting sensation. Particularly favored by veterans for pain and PTSD relief.

Peace Gummies — Developed directly from Colin’s experience with PTSD and benzodiazepine addiction. Helped him quit Xanax cold turkey. Also available in vape form for quick relief—Colin personally uses it for insomnia and severe PTSD.

Custom Creations — We design tailored products for specific needs: unique cannabinoid ratios, particular delivery formats, formulations for vegans, diabetics, or specific health circumstances.

Two Product Formats: Which Is Right For You?

RSO Sublingual Oil — $129.99

• 30mL bottle (1 fl oz)
• 16,590mg total cannabinoids (553mg/mL)
• Seven cannabinoids: CBD 4,500mg, CBG 3,000mg, delta-8 THC 6,000mg, THCa 1,500mg, delta-9 THC 90mg, CBN 750mg, CBC 750mg
• Live terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Organic MCT oil base
• Graduated dropper: 0.1mL increments for precise dosing
• Onset: 15-45 minutes (sublingual)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Approximately 40-60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900mg+ total cannabinoids
• Six cannabinoids: Same ratio as sublingual (THCa auto-decarbs at vaping temp)
• Live terpenes: 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%

When To Use Each Format

Use Case	Recommended Format	Why
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability/discretion	Vape	Compact, no measuring
Precise dosing	Sublingual	0.1mL increments
Daytime non-psychoactive	Sublingual (raw)	THCa stays inactive
Nighttime psychoactive	Sublingual (decarbed) or Vape	Full activation

For Candler County residents: If you’re dealing with chronic pain from agricultural work, the sublingual oil provides all-day relief. If you have breakthrough pain while working in the timber industry, the vape gives instant relief. If you need to function at your job at the hospital in Metter or drive your kids to school in the county, use the raw sublingual oil. If you’re dealing with severe cancer symptoms or nighttime anxiety, decarb it or use the vape.

Condition-Specific Usage Context

Important disclaimer: These contexts are informed by cannabinoid research cited in the GENERAL KNOWLEDGE section. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy, Agricultural/Timber Work Injuries)

For Candler County’s agricultural and timber workers: We know the toll that physical labor takes. Whether it’s back pain from lifting, joint pain from repetitive motion, or nerve damage from equipment operation, chronic pain is real here.

• Daytime: 0.3-0.5mL raw sublingual—provides anti-inflammatory cannabinoid exposure without psychoactive impairment so you can work safely
• Nighttime: 0.5-1.0mL decarboxylated sublingual—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Local context: If you’re traveling to the pain clinic in Statesboro or seeing a specialist in Savannah, our sublingual oil can complement your treatment plan. Discuss it with your doctor—many physicians in Georgia are becoming more open to cannabinoid therapy when presented with evidence.

Chemotherapy-Related Nausea and Appetite Support

For Candler County cancer patients traveling to treatment centers:

• Pre-chemo: 0.5-1.0mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Evidence: Delta-8 antiemetic evidence [9], delta-9 THC nausea evidence [1][13], CBD anxiolytic buffering [3]

Important: If you’re receiving treatment at the Lewis Cancer & Research Pavilion in Savannah or closer facilities in Statesboro, coordinate with your oncology team. Don’t replace proven therapies with RSO. Use it as complementary support for symptom management.

Sleep Support

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN—the dosage level investigated in 2024 sleep literature
• At 1.0mL: Delivers 25mg CBN—above the 20mg threshold associated with reduced sleep disturbance
• Evidence: CBN sleep evidence [16][17], cannabis and sleep review literature

For Candler County residents: Sleep disorders are common in rural areas, especially among those dealing with chronic pain or PTSD. If you’re in Metter or the surrounding areas and struggling with insomnia, this provides a natural alternative to prescription sleep medications.

Anxiety, Stress, and PTSD

For Candler County veterans and trauma survivors: We know PTSD affects rural communities deeply. The isolation, limited mental health resources, and stigma around seeking help make it harder.

• Daytime functional relief: 0.3mL raw sublingual—CBD and CBG address anxiety-related pathways without psychoactive impairment
• Nighttime: 1.0mL sublingual—full cannabinoid profile including CBN for sleep architecture
• Evidence: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

Local resources: If you’re a veteran in Candler County, connect with the Georgia Department of Veterans Service office in Metter. Our products can complement the therapy and support they provide, but they’re not a replacement for professional mental health care.

General Titration Principle

Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

For Candler County residents: If you’re new to cannabinoids, start on a day when you don’t have to work—maybe a Saturday after you’ve finished chores. See how your body responds before adjusting your dose.

Competitive Comparison: Why OilWell RSO Stands Apart

OilWell RSO vs. Georgia Medical Cannabis (Low-THC Oil)

Dimension	Georgia Medical Cannabis	OilWell RSO
Cannabinoid profile	THC-only (max 5% THC)	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG content	Minimal or none	3,000mg
CBN content	Minimal or none	750mg
CBC content	Minimal or none	750mg
Patient-controlled potency	No—always psychoactive	Yes—THCa non-psychoactive until you heat it
Access requirements	Medical card + qualifying condition	Age 21+ only, no medical card needed
Qualifying conditions	Cancer, PTSD (with strict criteria), terminal illness, etc.	None required
Delivery	Must travel to licensed dispensary (nearest may be in Macon or Atlanta)	Ships directly to your Candler County address
Farm Bill compliant	No—state medical program	Yes—less than 0.3% delta-9 THC

For Candler County residents: Georgia’s medical program requires you to have a qualifying condition, register with the state, and travel to a licensed dispensary—likely a 2-3 hour drive to Macon or Atlanta. Our product ships directly to Metter, Portal, Pulaski County, or anywhere in the area. No medical card needed. You control the potency. You decide if and when to activate the THCa.

OilWell RSO vs. Hemp CBD Products (e.g., from local shops)

Dimension	Typical Hemp CBD Product	OilWell RSO
Total cannabinoids	1,000mg (10mL bottle)	16,590mg (30mL bottle)
CBD content	~950mg	4,500mg
CBG content	Minimal	3,000mg
Delta-8 THC	Usually none	6,000mg
Psychoactive option	No	Yes—via THCa decarboxylation
Price	$40-50	$129.99

For Candler County residents: If you’ve tried CBD from the shop in Metter or ordered online and felt nothing, it’s likely because the cannabinoid content was too low or too limited. Our formula has 16 times more total cannabinoids and includes seven different compounds that work synergistically.

Delivery and Global Accessibility to Candler County

Shipping to Candler County, Georgia

Nationwide shipping: We ship to all 50 states where Farm Bill-compliant products are legal, including Georgia. Your order will arrive via USPS Priority Mail (2-3 business days), FedEx, or UPS Ground (3-5 business days).

For Candler County addresses:

• Metter, GA 30439 — 2-3 business days via USPS Priority Mail
• Portal, GA 30450 — 2-3 business days via USPS Priority Mail
• Unincorporated areas (Pulaski County line, etc.) — 2-3 business days via USPS Priority Mail

Discreet packaging: No cannabis branding visible on the exterior. Your privacy matters, especially in close-knit rural communities.

Tracking: Provided for all orders so you know exactly when it will arrive.

Temperature-stable packaging: Georgia summers are hot. We use packaging that protects the product during summer shipments.

Signature-required option: Available if you want added security.

What About Same-Day Delivery?

We operate same-day delivery in Houston’s Texas Medical Center and surrounding zones, but this service is not available in Candler County. However, our shipping is fast and reliable. Most Georgia orders arrive within 2-3 business days.

Pro tip for Candler County residents: Order by Monday morning and you’ll likely have it by Wednesday or Thursday—plenty of time to have it for the weekend when you can start your titration protocol on a non-work day.

International Shipping

We ship internationally. The THCa legal framework makes this possible: because the product contains less than 0.3% delta-9 THC at point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill.

Customer responsibility: You are responsible for verifying legality in your jurisdiction and accepting all customs and legal risk. We provide full documentation, Certificates of Analysis, and receipts for customs purposes.

General Knowledge: The Science Behind Every Compound

Research Method and Evidence Weighting

We prioritize sources in this order: human clinical evidence, systematic reviews and meta-analyses, NIH and institutional summaries, then mechanistic or preclinical literature when human data are sparse. This matters because the evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and preclinical pharmacology [1]-[29].

Institutional Baseline from NIH and Related Sources

• NCCIH states strongest established cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea/vomiting, and HIV/AIDS appetite/weight loss. Modest evidence exists for chronic pain and MS symptoms. Many other claimed uses remain early-stage [1].
• FDA has not approved the cannabis plant itself for medical use. Only purified CBD (Epidiolex) and synthetic THC-like drugs have specific approvals [1].
• Safety concerns highlighted by NIH: impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination/labeling inaccuracy, THC-vape lung injury [1].
• CBD safety: NCCIH flags diarrhea, sleepiness, appetite changes, mood effects, liver-function abnormalities, and drug-drug interactions [1].

Cannabinoid Profiles

CBD

• Evidence: Strongest human evidence in this formula set, especially as purified product [1]-[6].
• Best supported: Seizure disorders (Epidiolex) [1][2].
• Anxiety: 2024 systematic review of 316 participants found significant anxiolytic signal but stressed limited clinical sample [3].
• Pain: 2024 review concluded literature is promising but heterogeneous, limiting broad analgesic claims [4].
• Sleep: 2023 review found methodologically weak studies with few objective assessments [5].
• Safety: 2023 meta-analysis found liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products [6].
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications, not broad wellness claims [1]-[6].

CBG

• Evidence: Mostly review and preclinical; human evidence sparse [7][8].
• Pharmacology: Biosynthetic precursor to major cannabinoids; interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling—mechanistically interesting but not clinically established [7].
• Research areas: Possible relevance to neurologic disorders, inflammatory bowel disease, antibacterial activity—but primarily preclinical hypotheses [7][8].
• Caution: 2021 review notes CBG is commercially sold while evidence base remains thin [7].
• Bottom line: Serious research topic but should be described as promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC

• Evidence: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].
• Comparative pharmacology: 2022 review found delta-8 and delta-9 have broadly similar behavior; delta-8 is partial CB1 agonist, less potent due to weaker CB1 affinity [9].
• Public health: 2023 scoping review found evidence base dominated by animal studies, chemistry, use reports, and public-health concerns rather than strong human trials; noted adverse consequences and regulatory concerns [10].
• Manufacturing: 2024 review notes commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels, raising product byproduct and lab-testing questions [11].
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and manufacturing-quality uncertainty [9]-[11].

THCa

• Evidence: Important chemically and formulation-wise, but low on direct human therapeutic evidence [12].
• What it is: Acidic precursor of THC; may represent large share of THC-related content in raw plant material. Decarboxylates to THC during heating and can change during storage [12].
• Psychoactivity: THCa itself does not produce psychoactive effects—if it stays acidic and isn’t decarboxylated [12].
• Research: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities—not equivalent to established human outcomes [12].
• Bottom line: Highly relevant precursor molecule whose interpretation depends on route, temperature, processing, and storage [12].

Delta-9 THC

• Evidence: Strongest human evidence of psychoactive cannabinoids, but clearest adverse-effect burden [1][13]-[15].
• Institutionally supported: NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes [1].
• Pain: 2022 systematic review found high THC or comparable THC:CBD products may provide short-term pain benefit but increased dizziness, sedation, nausea, and discontinuation due to adverse events [13].
• Pharmacokinetics: Inhaled THC: effects within seconds-minutes, peak 15-30 minutes, taper over hours. Oral THC: later onset, later peak, longer duration—matters for benefit and overconsumption risk [14].
• Mental health risk: 2025 systematic review found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, with anxiety/depression signals [15].
• Broader safety: Anxiety/panic at high doses, tachycardia, blood-pressure changes, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15].
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN

• Evidence: Weak human evidence; marketing ahead of data [12][16][17].
• Marketing: Sleep and sedation—reputation widespread but clinical support thin [16][17].
• Sleep claim review: 2021 narrative review screened 99 abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].
• Broader literature: 2024 updated review concluded cannabinoid sleep research still doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17].
• Chemical context: THC can degrade toward CBN under certain conditions, explaining why CBN appears in aging/oxidized cannabis [12].
• Bottom line: Clearest example where cultural reputation is stronger than clinical evidence [16][17].

CBC

• Evidence: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19].
• Pharmacology: 2024 review describes distinct pharmacodynamics, pharmacokinetics, receptor behavior; highlights antinociceptive, antibacterial, anti-seizure as interesting targets [18].
• Older literature: Review summarizes anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance—but not strong evidence for patient-facing claims [19].
• Safety caveat: 2024 CBC review explicitly notes over-the-counter CBC products sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

Terpene Profiles

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence: Review and preclinical, with safety literature [20]-[22].
• Activity: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory—but overwhelming share from nonhuman/non-cannabis literature [21].
• Safety: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens important in patch-testing [22].
• Bottom line: Biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative [20]-[22].

Myrcene

• Evidence: Mostly preclinical, very limited human evidence [20][23].
• Research: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties and mechanisms, but explicitly states human studies lacking [23].
• Caution: Myrcene is often invoked as proven sedative explaining couch-lock—stronger claim than human evidence supports [20][23].
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims remain far ahead of definitive human proof [23].

Caryophyllene

• Evidence: Among most mechanistically interesting due to direct cannabinoid-system relevance, but mostly preclinical [24].
• Why it stands out: 2021 review describes beta-caryophyllene as selective CB2 receptor agonist—unusual, makes it especially relevant pharmacologically [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective—human clinical confirmation limited [24].
• Bottom line: Strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven [24].

Pinene

• Evidence: Promising preclinical literature, weak human confirmation [20][25].
• Brain-health framing: 2021 review found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized lack of well-designed clinical trials [25].
• Caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain interesting hypotheses, not settled facts [20][25].
• Bottom line: Deserves scientific attention, but strong cognition claims should be presented as exploratory [25].

Linalool

• Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].
• Research: Repeatedly discussed for stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation, but lack of robust human trials [25].
• Additional literature: Separate reviews discuss possible antidepressant mechanisms and neuropharmacologic relevance—translational rather than definitive clinical story [26].
• Safety: Oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22].
• Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene

• Evidence: Translationally interesting, but early [20][27].
• Scoping-review: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].
• Caution: Findings valuable for hypothesis generation, but do not yet establish consistent human efficacy [27].
• Bottom line: Interesting terpene research target, but remains far from clinically settled [27].

Terpinolene

• Evidence: One of least clinically characterized terpenes in this file [20][28].
• Systematic-review: 2021 review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base dominated by in silico, in vitro, and animal studies rather than human trials [28].
• Caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20].
• Bottom line: Biologically interesting, but especially underdeveloped clinically [20][28].

Research Limits and Interpretation

1. Evidence base is highly uneven. CBD and delta-9 THC support most detailed statements; others require more caution [1]-[29].
2. Extract/molecule/synthetic/terpene data aren’t interchangeable. Common error in cannabis writing is letting evidence from one category stand for another.
3. Minor cannabinoids and terpenes are commercially interesting precisely because underexplored, but that also means claims often inflated.
4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent pharmacokinetics materially affect interpretation [1][10][11][14].
5. For THCa, chemistry is destiny: storage and heating can change exposure profile by converting acidic cannabinoids to neutral cannabinoids like THC [12].

Common Overstatements to Avoid

• Overstatement: CBN is clinically proven sleep cannabinoid.
  Accurate: Specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base [16][17].
• Overstatement: Myrcene is proven human sedative explaining couch-lock.
  Accurate: Myrcene has plausible preclinical bioactivity, but direct human proof limited [20][23].
• Overstatement: Terpenes have proven entourage effects in patients.
  Accurate: Entourage hypotheses influential and worth studying, but robust clinical proof limited and highly compound-specific [20][29].
• Overstatement: THCa is always nonpsychoactive.
  Accurate: THCa itself is not THC, but heating/processing can convert THCa to THC [12].
• Overstatement: Delta-8 THC is safe because hemp-derived.
  Accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for These Formulas

• Most evidence-developed actives: CBD and delta-9 THC.
• Delta-8 THC: Not trivial or purely mild; psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC.
• THCa: Meaningfully changes with processing; interpret differently in raw vs. heated formats.
• CBG/CBN/CBC: Scientifically credible but clinically immature compared to CBD and THC.
• Terpenes: Likely highly relevant to aroma/flavor/possible biologic activity, but compound-specific human therapeutic claims should be careful and only where directly supported.

The Complete Formulas

RSO Sublingual Oil Formula

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle
• Carrier: Organic MCT oil
• Active per mL: 553mg

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1-gram cartridge
• Battery: 510-thread universal compatibility

Terpene Profile (Both Products)

• Limonene: Citrus-bright, mood-enhancing
• Myrcene: Relaxation, earthy depth
• Caryophyllene: Pepper/spice, CB2 activation
• Pinene: Forest-fresh, clarity
• Linalool: Floral lavender, calm
• Humulene: Earthy/woody, anti-inflammatory
• Terpinolene: Piney/fruity, complexity

For Candler County residents: If you’ve ever walked through the pine forests near George L. Smith State Park, you know the smell of pinene. If you’ve peeled an orange from a local grove, you’ve smelled limonene. These aren’t just chemical names—they’re sensory experiences that connect to your environment. Our terpene profile makes the product experience richer and potentially more effective through the entourage effect.

Safety, Legal, and Ordering Information

Age and Legal Requirements

• Must be 21+ to purchase RSO products.
• Georgia law: Hemp-derived products with less than 0.3% delta-9 THC are legal. Our product contains only 90mg delta-9 THC in the entire 30mL bottle—well under 0.3%.
• Customer responsibility: You are responsible for understanding and complying with Georgia law regarding THCa conversion. We provide full documentation; you make the informed decision.

FDA Disclaimer

These products have not been evaluated by the Food and Drug Administration. They are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult a healthcare provider before use.

Safety Warnings

• May cause drowsiness or impairment. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.
• Consult your physician if pregnant, nursing, or have any medical conditions.
• Keep out of reach of children and pets.
• Store in a cool, dry place away from direct sunlight.

Drug Testing Warning

THCa in raw form will NOT cause a positive drug test. However, delta-8 THC WILL cause a positive test. Fully decarboxylated THCa (converted to delta-9 THC) WILL cause a positive test. If your employer in Candler County drug tests, use the raw form only or discuss with your HR department.

How to Order

Online: Visit oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

Phone: (832) 416-2816

Email: [email protected]

Business Hours:

• Monday-Thursday: 10:00 AM – 7:00 PM
• Friday-Saturday: 10:00 AM – 10:00 PM
• Sunday: 10:00 AM – 4:00 PM

Address for reference:
810 Richmond Ave, Houston, TX 77006 (Montrose neighborhood)

Special Note for Candler County Customers

We understand that ordering cannabis products online to a rural address can feel uncertain. Here’s what you can expect:

1. Order confirmation within minutes via email
2. Tracking number within 24 hours
3. Discreet packaging—a plain box with no cannabis branding
4. Delivery to your door in 2-3 business days via USPS Priority Mail
5. COA included—lab results documenting exactly what’s in your product

If you have any questions about dosing, decarboxylation, or how to use the product safely in your specific situation, call us. We’re real people who answer the phone and provide honest guidance.

Final Thoughts for Candler County

We started this guide by telling you we wouldn’t sell you snake oil. We hope we’ve delivered on that promise.

Rick Simpson’s story is powerful because it represents hope when conventional medicine fails. It’s the story of a regular person who took health into his own hands. But hope without evidence can be dangerous, especially when dealing with cancer or other serious conditions. That’s why we’ve built OilWell on a foundation of both heart and science—the heart that drove Colin to save Bentley, and the science that comes from working with institutions like Baylor College of Medicine.

For Candler County residents dealing with chronic pain from agricultural work, cancer treatment in Savannah, PTSD from military service, anxiety from economic uncertainty, or sleep disorders from any of the above—we’ve created a product that gives you control. Control over potency. Control over when and how you use it. Control over your own health decisions.

The media record shows we’ve been consistent for years. The science shows we’ve done our homework. The formula shows we’ve innovated beyond traditional RSO. And the story shows we’ve lived the same struggles you’re facing.

We’re not here to tell you cannabis will cure your cancer. We’re here to tell you that cannabinoids have real, evidence-supported benefits for symptom management, quality of life, and in some cases, specific medical indications. We’re here to give you the best possible version of the information so you can give it a fair shot and decide if it’s right or wrong for you.

From our Houston facility to your doorstep in Metter, from our open-source formulas to your kitchen table in Pulaski County, from our third-party lab tests to your peace of mind in Candler County—we’re committed to integrity, transparency, and your right to make informed decisions about your health.

Order today. Ask questions. Be skeptical. Read the science. And whatever you decide, know that we’re here to support you with honest information and products made with intent.

OilWell Cannabis
810 Richmond Ave, Houston, TX 77006
(832) 416-2816
oilwellcbd.com